We are live on
!
Find out more
TCT
TIAA CREF Trust Portfolio holdings
AUM
$13.8B
1-Year Est. Return
10.67%
This Fund
S&P 500
This Quarter
Est. Return
+2.26%
1 Year Est. Return
+10.67%
3 Year Est. Return
+14.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$648M
(+6.3%)
Cap. Flow
+$430M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
53.26%
Holding
357
New
31
Increased
168
Reduced
140
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$60.2M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$49.7M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$33.5M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$31.7M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$5.75M |
| 2 |
Analog Devices
ADI
|
+$4.02M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$3.61M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$3.53M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$3.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.71% |
| 2 | Financials | 2.04% |
| 3 | Consumer Staples | 1.7% |
| 4 | Technology | 1.7% |
| 5 | Industrials | 1.56% |
Similar funds
EAM
PIM
EPCM
ICM
AIU
LAM
LT
EMA
TIAA CREF Trust's Q2 2016 Portfolio in Review
As of Q2 2016, TIAA CREF Trust held 357 positions worth $10.9B, up 6.3% from $10.2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
TIAA CREF Trust deployed $430M of net new capital in Q2 2016, opening 31 new positions and adding to 168 existing holdings. Its largest new stake was Amazon: 218,760 shares worth $7.83M.
By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 2.7% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Biogen, an estimated $5.75M trimmed.
- TIAA CREF Trust's largest Q2 2016 buy was Amazon: 218,760 shares worth $7.83M.
- TIAA CREF Trust added most to iShares TIPS Bond ETF in Q2 2016, an estimated $60.2M increase.
- TIAA CREF Trust's biggest Q2 2016 reduction was Biogen, cutting an estimated $5.75M.
- TIAA CREF Trust fully exited Regeneron Pharmaceuticals in Q2 2016, selling an estimated $3.61M.
- TIAA CREF Trust's ten largest holdings make up 53% of its $10.9B portfolio in Q2 2016.
- TIAA CREF Trust opened 31 new positions and closed 12 in Q2 2016.
- TIAA CREF Trust's portfolio value rose 6.3% quarter-over-quarter to $10.9B.
Based on TIAA CREF Trust's 13F filing for Q2 2016, filed 21 Jul 2016.